LBPH — Longboard Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $1.05bn
- $729.88m
- 36
- 30
- 92
- 51
Annual cashflow statement for Longboard Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -14.4 | -27.8 | -43.9 | -54.4 |
| Depreciation | ||||
| Non-Cash Items | 8.51 | 2.12 | 2.76 | 2.28 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | 2.45 | 0.967 | 3.12 | 1.27 |
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Net Change in Other Assets & Liabilities | ||||
| Cash from Operating Activities | -3.44 | -24.7 | -38.1 | -50.9 |
| Capital Expenditures | — | -0.016 | 0 | — |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | -40.7 | -17.1 | 24.2 |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | — | -40.7 | -17.1 | 24.2 |
| Financing Cash Flow Items | -0.442 | -8.32 | -0.444 | -2.09 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Cash from Financing Activities | 58.8 | 76.5 | -0.444 | 30.2 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 55.3 | 11 | -55.6 | 3.56 |